» Articles » PMID: 31929890

Sudden 'cure' of Type Two Diabetes Due to Pancreatic Insulinoma: A Case Report

Overview
Journal Mol Clin Oncol
Specialty Oncology
Date 2020 Jan 14
PMID 31929890
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Insulinomas are rare tumors of the islet cells of the pancreas and are the most common cause of endogenous hyperinsulinism. Although they usually present with symptoms of hypoglycemia, sometimes they can have vague symptoms. We present the case of a 62-year-old diabetic female who was diagnosed with a large insulinoma after being investigated for the 'cure' of her diabetes. We also review the literature regarding insulinomas in patients with diabetic. A 62-year-old, obese woman with type 2 diabetes mellitus was initially investigated for an unexplained normalization of her blood glucose levels after the cessation of antidiabetic medication due to an episode of severe hypoglycemia. She remained without antidiabetics for three months maintaining normoglycemia, and thereafter, she started experiencing frequent but less severe hypoglycemic episodes. She did not change her diet habits or level of activity and did not lose any weight. The patient underwent further investigation with a supervised 72 h fasting test, which resulted in the biochemical diagnosis of endogenous hyperinsulinism. Imaging studies revealed the presence of a large insulinoma in the head of the pancreas. Finally, the patient underwent a pylorus preserving Whipple procedure, which reversed the aforementioned 'normalization' of glucose levels and the underlying diabetes mellitus reappeared. Insulinomas are rare tumors causing hypoglycemia. Even more rarely are found in diabetic patients, making the diagnosis more challenging and probably delayed, as the symptoms are masked by the presence of diabetes, thereby leading to a more advanced disease diagnosis.

Citing Articles

Insulinoma in Patients with Diabetes- A Systematic Review of Previously Reported Cases.

Chatterjee S, Bhattacharjee R, Ghosh R, Chakraborty P, Sinha A, Maiti A Indian J Endocrinol Metab. 2025; 28(6):554-561.

PMID: 39881762 PMC: 11774416. DOI: 10.4103/ijem.ijem_154_24.


Case Report: Insulinoma Co-Existing With Type 2 Diabetes - Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation.

Chang J, Woo C, Lui D, Fung M, Lee A, Leung E Front Endocrinol (Lausanne). 2022; 13:957369.

PMID: 35942178 PMC: 9355856. DOI: 10.3389/fendo.2022.957369.

References
1.
Siraj E, Samuel G, Saber S, Samuel S, Hamrahian A, Reddy S . Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus: case presentation and literature review. Endocr Pract. 2006; 12(4):411-6. DOI: 10.4158/EP.12.4.411. View

2.
Atkinson A, Buchanan K, Carson D, Kennedy T, OHARE M, Sloan J . Insulinoma (apud cell carcinoma) in a diabetic. Br Med J. 1978; 2(6149):1397-8. PMC: 1608570. DOI: 10.1136/bmj.2.6149.1397-a. View

3.
Gotz W, Schucht C, Roth J, Theuring F, Herken R . Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice. Am J Pathol. 1993; 142(5):1493-503. PMC: 1886916. View

4.
Stefanovski D, Richey J, Woolcott O, Lottati M, Zheng D, Harrison L . Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. PLoS One. 2011; 6(3):e18134. PMC: 3068147. DOI: 10.1371/journal.pone.0018134. View

5.
Bhatti T, Ganapathy K, Huppmann A, Conlin L, Boodhansingh K, MacMullen C . Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect. J Clin Endocrinol Metab. 2016; 101(3):914-22. PMC: 4803165. DOI: 10.1210/jc.2015-2914. View